{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-05T12:23:52.754758+00:00",
  "news": [
    {
      "title": "The Blockbusters That Drove Amgen's Third-Quarter Beat - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOQVBMdzc4U3E2WTMtQ09CdTdCSU4xbWEzb1NxSUNPcW1uU2lRVGR0T1M1WnVCSjl0eVFzb3FsUzlKTTBSNnM5NzV3WlU4ZGYyNWt5TExzQTNCUDl3TWFwR0FFb3lGMjNCdmZlMTFvSUpkSE9ZMENoWGx2UzZ0THUtNmFyRQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxOQVBMdzc4U3E2WTMtQ09CdTdCSU4xbWEzb1NxSUNPcW1uU2lRVGR0T1M1WnVCSjl0eVFzb3FsUzlKTTBSNnM5NzV3WlU4ZGYyNWt5TExzQTNCUDl3TWFwR0FFb3lGMjNCdmZlMTFvSUpkSE9ZMENoWGx2UzZ0THUtNmFyRQ?oc=5\" target=\"_blank\">The Blockbusters That Drove Amgen's Third-Quarter Beat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-04T21:20:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump - WSJ - The Wall Street Journal",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump - WSJ</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font>",
      "published": "2025-11-04T21:33:00+00:00",
      "source": "The Wall Street Journal"
    },
    {
      "title": "AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPeHpZYzRkSDBaNi0tX1B0R2pRMnNFQ1dTb0NXcGUzeUdtZ0h4eWFSSHVqTUpRYnE0ektZbXJ4dGk0QnBReFpNVlJJbDJnSnllVmZuMjIyWGRrTW5BYnlmWkFRVHY3WXJpd3ZRRTZyYWV3QVhxZDJ3ajdTS1h1TXY1MTJxOEFLTjJxbFJ1WlNQVTVuLU9sY01Nb29TMEhJaE5ta0FlUDlSTUdOUQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPeHpZYzRkSDBaNi0tX1B0R2pRMnNFQ1dTb0NXcGUzeUdtZ0h4eWFSSHVqTUpRYnE0ektZbXJ4dGk0QnBReFpNVlJJbDJnSnllVmZuMjIyWGRrTW5BYnlmWkFRVHY3WXJpd3ZRRTZyYWV3QVhxZDJ3ajdTS1h1TXY1MTJxOEFLTjJxbFJ1WlNQVTVuLU9sY01Nb29TMEhJaE5ta0FlUDlSTUdOUQ?oc=5\" target=\"_blank\">AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-11-04T21:01:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen Ventures joins $141M Series B for Italian gene therapy biotech AAVantgarde - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOZWlJVzV0VjRKWHlZVENETTNhY0RUa3Z5bTZITVlGQmJZa3BCNk1VVDRTRWpKQUMtd1FPQm9pUUpld2t4OGVhUmJITHJqeWxIVm1UYXZXQmI0dXRLLWpnTzdqZzFCc2Z5ZzRFUjNkRkhkVmJCRFlMWVBzOXhhZnV5bThRUElTNzRVazJYeWVtWGRCTnVndjRlamtNQVJLT0lLVW9GemJB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxOZWlJVzV0VjRKWHlZVENETTNhY0RUa3Z5bTZITVlGQmJZa3BCNk1VVDRTRWpKQUMtd1FPQm9pUUpld2t4OGVhUmJITHJqeWxIVm1UYXZXQmI0dXRLLWpnTzdqZzFCc2Z5ZzRFUjNkRkhkVmJCRFlMWVBzOXhhZnV5bThRUElTNzRVazJYeWVtWGRCTnVndjRlamtNQVJLT0lLVW9GemJB?oc=5\" target=\"_blank\">Amgen Ventures joins $141M Series B for Italian gene therapy biotech AAVantgarde</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-11-03T08:00:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Amgen halts gastric cancer trial after antibody ‘did not meet our standard’ of efficacy - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5\" target=\"_blank\">Amgen halts gastric cancer trial after antibody ‘did not meet our standard’ of efficacy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-11-05T09:35:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen profit beats estimates, weight-loss data due by year-end - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTFhWNmE5bXpTQkRnd2Frb1l4VzFqU3NJOEttZFQ3NENPRXU3QjRjMjJiRHJyT29oVWFvSllzUDdHZmxIVlB1aF9tUmF2YlNlaDBRdE9MR2pkbjMtanh3Sm1FWWQ3c3pHTnBJd1JKTElORGsxZXBIQVhfN2JPY3R6X1RpaFJrQ3BQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTFhWNmE5bXpTQkRnd2Frb1l4VzFqU3NJOEttZFQ3NENPRXU3QjRjMjJiRHJyT29oVWFvSllzUDdHZmxIVlB1aF9tUmF2YlNlaDBRdE9MR2pkbjMtanh3Sm1FWWQ3c3pHTnBJd1JKTElORGsxZXBIQVhfN2JPY3R6X1RpaFJrQ3BQ?oc=5\" target=\"_blank\">Amgen profit beats estimates, weight-loss data due by year-end</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-04T22:17:02+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen Lifts Outlook Again After Drug Sales Beat Expectations (AMGN) - Bloomberg.com",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNQ2E2STIzRjFjTDIwZDZCa3RPQUI1VGQ0ZVBkOWtWT29FV3FidUVSWFJ0bmZpUF9lc3dqVFQ5S3hHa0szbTkwSTltMmxrVnRPWXVXMmphM2IyRzZQb2FIejl0YzZlTGxGY2FIZDNZc0NkLVk1b09LeTdOMkpoS1RGVzR4TzhRcE9Gel9STWpPNWdzTGk5WEJINk1oaFg2d1ZjRG9lWUY1Z0xoemlPUnZIOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNQ2E2STIzRjFjTDIwZDZCa3RPQUI1VGQ0ZVBkOWtWT29FV3FidUVSWFJ0bmZpUF9lc3dqVFQ5S3hHa0szbTkwSTltMmxrVnRPWXVXMmphM2IyRzZQb2FIejl0YzZlTGxGY2FIZDNZc0NkLVk1b09LeTdOMkpoS1RGVzR4TzhRcE9Gel9STWpPNWdzTGk5WEJINk1oaFg2d1ZjRG9lWUY1Z0xoemlPUnZIOA?oc=5\" target=\"_blank\">Amgen Lifts Outlook Again After Drug Sales Beat Expectations (AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg.com</font>",
      "published": "2025-11-04T22:43:11+00:00",
      "source": "Bloomberg.com"
    },
    {
      "title": "Amgen Inc. Reports Strong Q3 2025 Financial Results - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOdGlsUG5EVUF6NS1wbGJoQlg1U2NGaVBVYmh4VWk5SERQTDBUTklGUWktcENPQzNSWGFKU1RJanB0N1gyRFBMWlJXcmZIeDZWdkpxWUNwbmo4YWZMU0IwWHVZSE9wUHNVVThqTXhOenlueVZyYjVVV3NrcG5CMWNsOXNmczlzWWt0RUJ4YmxrdnhNRnR0a0t5SGxsVkdXSzkycklnTA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxOdGlsUG5EVUF6NS1wbGJoQlg1U2NGaVBVYmh4VWk5SERQTDBUTklGUWktcENPQzNSWGFKU1RJanB0N1gyRFBMWlJXcmZIeDZWdkpxWUNwbmo4YWZMU0IwWHVZSE9wUHNVVThqTXhOenlueVZyYjVVV3NrcG5CMWNsOXNmczlzWWt0RUJ4YmxrdnhNRnR0a0t5SGxsVkdXSzkycklnTA?oc=5\" target=\"_blank\">Amgen Inc. Reports Strong Q3 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-11-05T04:20:31+00:00",
      "source": "TipRanks"
    }
  ],
  "product_launches": [
    {
      "title": "AMGEN INC SEC 10-Q Report - TradingView",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPLWF3RE1KR2s2WllnYnFjZUNKQlJTWFBhRDFTQ3N6TVN1QjR4ME9KOUltb0NpTFI2Ylh3THNsbVR6UV96OVpvZDFNZ2dEQTFzOW5RT0ItWXVmanQ0dGQ3LXlqeThNdHVzeU90VXJzcHZKZHJBeVpZNko2QUo2aTh0U3hseVpmbEFVODVvdUxjM1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPLWF3RE1KR2s2WllnYnFjZUNKQlJTWFBhRDFTQ3N6TVN1QjR4ME9KOUltb0NpTFI2Ylh3THNsbVR6UV96OVpvZDFNZ2dEQTFzOW5RT0ItWXVmanQ0dGQ3LXlqeThNdHVzeU90VXJzcHZKZHJBeVpZNko2QUo2aTh0U3hseVpmbEFVODVvdUxjM1E?oc=5\" target=\"_blank\">AMGEN INC SEC 10-Q Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2025-11-05T11:03:00+00:00",
      "source": "TradingView"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients - MyChesCo",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5\" target=\"_blank\">Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MyChesCo</font>",
      "published": "2025-10-27T04:00:00+00:00",
      "source": "MyChesCo"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-11-04",
      "close": 296.70001220703125
    },
    "history": [
      {
        "date": "2025-10-27",
        "close": 291.1600036621094
      },
      {
        "date": "2025-10-28",
        "close": 292.0899963378906
      },
      {
        "date": "2025-10-29",
        "close": 291.7699890136719
      },
      {
        "date": "2025-10-30",
        "close": 292.0
      },
      {
        "date": "2025-10-31",
        "close": 298.42999267578125
      },
      {
        "date": "2025-11-03",
        "close": 296.29998779296875
      },
      {
        "date": "2025-11-04",
        "close": 296.70001220703125
      }
    ],
    "name": "Amgen Inc."
  }
}